Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
IDT Host Workshop at PAG for Practical Insight into Novel Gene Constructs
Friday, January 04, 2013
Application-orientated information for gBlocks™ Gene Fragments.

Direvo Introduces BluCon™
Friday, November 16, 2012
Conversion of non-food biomass to biofuel and chemical building blocks.

Direvo Introduces BluZy™-Product Development Platform
Tuesday, October 09, 2012
New innovative enzyme technologies improving economics for the ethanol and livestock feeding industries.

Bruker Introduces the PesticideScreener™ Solution at Food Safety Conference
Monday, October 08, 2012
PesticideScreener is comprehensive solution for pesticide and plant metabolite screening using market-leading accurate-mass UHR-QTOF mass spectrometry with an information-rich 700 compound database, and rigorously tested methods in accordance with EU SANCO guidelines.

NatureNetting™ - A New Environmentally Friendly Material
Monday, October 08, 2012
The only compostable screening material currently approved and available commercially.

Determining the Oxidation Stability of Natural Oils and Fats
Thursday, October 04, 2012
Metrohm is pleased to publish a range of new application notes on the fast and reliable determination of 12 natural oils and fats using the just released 892 Professional Rancimat.

Connect with Takara Bio Europe at ELRIG Drug Discovery 2012
Tuesday, September 04, 2012
Connect with Takara Bio at booth M3 at the DD2012 in Manchester and win a Google Nexus 7 tablet.

Dyadic Demonstrates Industry-leading Biofuels Enzyme Performance
Tuesday, July 17, 2012
AlternaFuel® CMAX3(TM) performance equals and surpasses leading biofuels enzymes.

PSE Releases Major Update of gCRYSTAL Process Modelling Software
Thursday, June 21, 2012
Leading batch operation tool now guides batch-to-continuous R&D and Engineering efforts.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 99
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv